- A quick synopsis gives the pocket version of the Infectious Diseases Society of America’s (IDSA) guidelines for diagnosing and managing children and adults with suspected or confirmed infectious diarrhea.
Why this matters
- Infectious diarrhea hits almost 200 million people each year in the United States.
- Although most patients do not require anything but supportive care, some need antimicrobial therapies.
- Guidelines target children and adults with suspected or confirmed infectious diarrhea.
- With fever, blood/mucoid stools, severe abdominal pain, sepsis: test stool for Salmonella, Shigella, Campylobacter, Yersinia, Clostridium difficile, and Shiga toxin–producing Escherichia coli.
- Testing not recommended for uncomplicated traveler’s diarrhea
- With bloody diarrhea and no sepsis, antibiotics should be avoided in most immunocompetent patients.
- Probiotics might reduce symptom severity, duration (other guidelines differ).
- Synopsis authors urge balancing benefits-harms in considering multiplex molecular testing.
- Another synopsis is available for IDSA guidelines targeting US population with persistent or infectious diarrhea .